Skip to primary content
Skip to secondary content

Biotech 365

Main menu

  • Biotech 365
  • Companies
  • Healthcare Investors
    • Healthcare LPs
  • Healthcare Investors Matchmaking
  • Free DEMO
  • Services
    • Preclinical Studies Database
    • Scientific Due Diligence
    • CRO & CDMO Database
  • Contact

Tag Archives: IgG

Biomay – recombinant allergens

Posted on by

Biomay is a biotech company discovering and developing innovative allergy therapeutics. Biomay is a leader in the diagnostic and therapeutic use of recombinant allergens.

Biomay – recombinant allergens

biomay Continue reading →

Posted in Biotech Companies, Biotech Companies Austria | Tagged Active Pharmaceutical Ingredients, allergen, allergen-specific immunotherapy, allergens, allergic, allergic patients, allergy, allergy therapeutics, Angela Neubauer, antihistamine, antihistamines, API, APIs, Biomay, Biomay - recombinant allergens, birch pollen allergies, birch pollen allergy, BM31, BM32, grass pollen allergies, grass pollen allergy, Hans Huber, Hans Ulrich Wahn, IgE, IgG, Karl Fister, Marek Jutel, Marianne van Hage, peptide carrier fusion vaccine, peptide carrier fusion vaccines, Peter Creticos, pharmacotherapy, Rainer Henning, recombinant allergen, recombinant allergens, SIT, Stephen Durham, therapeutics

        Services              Healthcare Investors Database              FAQs               CGU               Biotech & Pharma News             Contact
Proudly powered by WordPress